Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daryl Tan-Yeung Lau, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U19AI088778 (GALE, MICHAEL J) Apr 1, 2010 - Mar 31, 2015
    Center for the Study of Innate Immunity to HCV Infection
    Role: Co-Principal Investigator
  2. U01DK082919 (LAU, DARYL T) Sep 30, 2008 - May 31, 2021
    Harvard Hepatitis B Consortium
    Role: Co-Principal Investigator
  3. R01DK068598 (LAU, DARYL T) Sep 20, 2005 - Aug 31, 2011
    Racial Differences in IFN Transcriptional Response
    Role: Principal Investigator
  4. M01RR000073 (ANDERSON, GARLAND D) Dec 1, 1978 - Mar 31, 2010
    General Clinical Research Center
    Role: Co-Principal Investigator
  5. M01RR001032 (SUKHATME, VIKAS P) Dec 1, 1977 - Mar 31, 2010
    General Clinical Research Center
    Role: Co-Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lau DTY, Ganova-Raeva L, Wang J, Mogul D, Chung RT, Lisker-Melman M, Chang KM, Shaikh OS, Janssen HLA, Wahed AS, Lok AS. Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes. Hepatology. 2021 May; 73(5):1637-1651. PMID: 32860463.
    Citations:    Fields:    
  2. Lu F, Shah PA, Rao A, Gifford-Hollingsworth C, Chen A, Trey G, Soryal M, Talat A, Aslam A, Nasir B, Choudhry S, Ishtiaq R, Sanoff H, Conteh LF, Noonan A, Hu KQ, Schmidt C, Fu M, Civan J, Xiao G, Lau DT, Lu X. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma. Clin Transl Gastroenterol. 2020 12; 11(12):e00271. PMID: 33512798.
    Citations:    Fields:    
  3. Hanif H, Khan MM, Ali MJ, Shah PA, Satiya J, Lau DTY, Aslam A. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. Microorganisms. 2020 Oct 04; 8(10). PMID: 33020450.
  4. Shah PA, Onken A, Ishtiaq R, Maqsood MH, Patel SS, Campoverde Reyes KJ, Herskovits AZ, Lau DTY. A challenging case of alpha-fetoprotein-result discrepancies in a patient with chronic hepatitis B. Gastroenterol Rep (Oxf). 2020 Dec; 8(6):484-486. PMID: 33447392.
  5. Talat A, Shah PA, Lau DTY, Russo NW, Brown RS, Amir M, Reshamwala P, Fortune B, Jalan-Sakrikar N, Schwartz RE. Hepatology Highlights. Hepatology. 2020 08; 72(2):369-370. PMID: 32841401.
    Citations:    Fields:    
  6. Maqsood MH, Kolli H, Kaur SP, Campoverde Reyes KJ, Guevara J, Shah PA, Talat A, Lau DTY. Improved hepatitis A and hepatitis B vaccination strategy is necessary for patients with chronic hepatitis C. Gastroenterol Rep (Oxf). 2020 Aug; 8(4):326-328. PMID: 32843981.
  7. Shah PA, Kaur S, Simons B, Talat A, McMahon B, Lau DTY. Patterns of HBeAg and HBsAg clearance among a treatment-naive Alaskan Cohort in a long-term observational study. J Viral Hepat. 2020 06; 27(6):644-646. PMID: 32043714.
    Citations:    Fields:    
  8. Shah PA, Choudhry S, Reyes KJC, Lau DTY. An update on the management of chronic hepatitis D. Gastroenterol Rep (Oxf). 2019 Dec; 7(6):396-402. PMID: 32494363.
    Citations: 1     
  9. Aslam A, Ishtiaq R, Lau DTY. Timely Administration of Birth Dose Hepatitis B Virus Vaccine May Break the Chain of Perinatal Transmission. Hepatology. 2019 05; 69(5):2284-2286. PMID: 30372542.
    Citations:    Fields:    Translation:HumansCells
  10. Aslam A, Campoverde Reyes KJ, Malladi VR, Ishtiaq R, Lau DTY. Management of chronic hepatitis B during pregnancy. Gastroenterol Rep (Oxf). 2018 Nov; 6(4):257-262. PMID: 30430013.
    Citations: 2     
  11. Aslam A, Susheela A, Iriana S, Chan SS, Lau D. Acute hepatitis E superinfection leading to chronic hepatitis B reactivation. BMJ Case Rep. 2018 Jun 10; 2018. PMID: 29891510.
    Citations: 2     Fields:    Translation:HumansCells
  12. Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau DT, Nguyen MH. Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B. J Clin Gastroenterol. 2018 03; 52(3):255-261. PMID: 28323748.
    Citations: 9     Fields:    Translation:HumansCells
  13. Safaie P, Poongkunran M, Kuang PP, Javaid A, Jacobs C, Pohlmann R, Nasser I, Lau DT. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World J Gastroenterol. 2016 Mar 28; 22(12):3404-11. PMID: 27022222.
    Citations: 2     Fields:    Translation:HumansCells
  14. Javaid A, Poongkunran M, Allard FD, Kyaw W, Maung HH, Lau D. Subtle presentation of active primary biliary cirrhosis in chronic hepatitis B: a case report. Gastroenterol Rep (Oxf). 2017 05; 5(2):157-160. PMID: 26893441.
    Citations: 1     
  15. Lake-Bakaar GV, Lau D, Kuang PP, Singh K. Controlled Therapy Interruption Improves Host Immune Control of Chronic Hepatitis B Virus Infection in HBeAg-Positive Patients. Viral Immunol. 2015 Dec; 28(10):564-9. PMID: 26501982.
    Citations:    Fields:    Translation:Humans
  16. Tapper EB, Krajewski K, Lai M, Challies T, Kane R, Afdhal N, Lau D. Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease. Gastroenterol Rep (Oxf). 2014 Nov; 2(4):276-80. PMID: 25002154.
    Citations: 20     
  17. Safaie P, Ham M, Kuang P, Mehta AS, Wang M, Cheifetz AS, Robson S, Lau D, Block TM, Moss AC. Lectin-reactive anti-a-gal in patients with Crohn's disease: correlation with clinical phenotypes. Inflamm Bowel Dis. 2013 Dec; 19(13):2796-800. PMID: 24185312.
    Citations:    Fields:    Translation:Humans
  18. Wilkins C, Woodward J, Lau DT, Barnes A, Joyce M, McFarlane N, McKeating JA, Tyrrell DL, Gale M. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology. 2013 Feb; 57(2):461-9. PMID: 22996292.
    Citations: 84     Fields:    Translation:HumansCells
  19. Lau DT, Negash A, Chen J, Crochet N, Sinha M, Zhang Y, Guedj J, Holder S, Saito T, Lemon SM, Luxon BA, Perelson AS, Gale M. Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection. Gastroenterology. 2013 Feb; 144(2):402-413.e12. PMID: 23123437.
    Citations: 33     Fields:    Translation:HumansCells
  20. Jamma S, Hussain G, Lau DT. Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony. Curr Hepat Rep. 2010; 9(4):260-269. PMID: 21258658.
    Citations: 12     
  21. Liang Y, Shilagard T, Xiao SY, Snyder N, Lau D, Cicalese L, Weiss H, Vargas G, Lemon SM. Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology. 2009 Oct; 137(4):1448-58. PMID: 19632233.
    Citations: 88     Fields:    Translation:HumansCells
  22. Lau DT, Bleibel W. Current status of antiviral therapy for hepatitis B. Therap Adv Gastroenterol. 2008 Jul; 1(1):61-75. PMID: 21180515.
    Citations: 5     
  23. Lau DT, Fish PM, Sinha M, Owen DM, Lemon SM, Gale M. Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology. 2008 Mar; 47(3):799-809. PMID: 18203148.
    Citations: 50     Fields:    Translation:HumansCells
  24. Tripathi RL, Krishnan P, He Y, Middleton T, Pilot-Matias T, Chen CM, Lau DT, Lemon SM, Mo H, Kati W, Molla A. Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient sera. Antiviral Res. 2007 Jan; 73(1):40-9. PMID: 16914212.
    Citations: 15     Fields:    Translation:HumansCells
  25. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, Carney DS, Wang T, Ishida H, Yoneyama M, Fujita T, Saito T, Lee WM, Hagedorn CH, Lau DT, Weinman SA, Lemon SM, Gale M. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A. 2006 Apr 11; 103(15):6001-6. PMID: 16585524.
    Citations: 190     Fields:    Translation:HumansCells
  26. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology. 2005 Sep; 42(3):702-10. PMID: 16108059.
    Citations: 91     Fields:    Translation:HumansCells
  27. Lau DT, Luxon BA, Xiao SY, Beard MR, Lemon SM. Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology. 2005 Aug; 42(2):273-81. PMID: 15986378.
    Citations: 24     Fields:    Translation:Humans
  28. Lau DT, Membreno FE. Antiviral therapy for treatment-naïve hepatitis B virus patients. Gastroenterol Clin North Am. 2004 Sep; 33(3):581-99, ix-x. PMID: 15324945.
    Citations: 1     Fields:    Translation:Humans
  29. Lau DT, Ma H, Lemon SM, Doo E, Ghany MG, Miskovsky E, Woods GL, Park Y, Hoofnagle JH. A rapid immunochromatographic assay for hepatitis B virus screening. J Viral Hepat. 2003 Jul; 10(4):331-4. PMID: 12823602.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  30. Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology. 1998 Oct; 28(4):1121-7. PMID: 9755252.
    Citations: 32     Fields:    Translation:HumansCellsCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Lau's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (107)
Co-Authors (17)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.